MEA Header

Eye News & Views

a newsletter for Medical Professionals

January 2014

In This Issue

Stay Connected

Like us on Facebook

Follow us on Twitter

View our profile on LinkedIn

Find us on Pinterest

MEA Happenings

Cynthia Matossian, MD, FACS participated as faculty at the Bausch + Lomb Headquarters in Tampa, Florida on December 6-7th to discuss the latest cataract surgery techniques for the resident mentor program.


Cynthia Matossian, MD, FACS participated as a panelist in MARCO's AAO meeting 'Power Forum 2' event.

Cynthia Matossian, MD, FACS participated as a panelist at Review of Ophthalmology in New Orleans, Louisiana on November 17th to discuss Laser and Cataract Surgery with Toric IOLs.

Cynthia Matossian, MD, FACS participated as faculty at the Hawaiian Eye Meeting on January 18-24th to discuss Toric IOLs.

Cynthia Matossian, MD, FACS presented a variety of lectures on ophthalmic products, medications and/or surgical techniques throughout the United States to many groups of ophthalmologists.
EyeWire TV

Cynthia Matossian, MD discusses Patient Satisfaction concepts after cataract surgery on EyeWire TV. To view the video, click here or select the icon below:

Month, Year
Sjögren's Syndrome Detection

Matossian Eye Associates is now able to test for Sjorgen's Syndrome through a simple test performed in our office. Sjö™ is a proprietary laboratory test developed by Immco Diagnostics Inc. and distributed by Nicox which combines traditional markers with three novel, proprietary biomarkers, allowing earlier detection of the disease. MEA is in a unique position to detect early stages of Sjögren's Syndrome as dry eye is one of the early hallmarks.

Sjögren's Syndrome is among the most common and underdiagnosed autoimmune diseases. It affects approximately 4 million people in the US, of which 3 million are undiagnosed. Currently, there is an average delay of 4.7 years for patients to receive an accurate diagnosis, and patients are often diagnosed in late stages of the disease after gland degradation has taken effect. Earlier detection is important to allow time for proper management. MEA hopes to enhance the lives of the 1 in 10 estimated Dry Eye Patients who may actually be suffering from Sjögren's Syndrome.

Month, Year
Bridging the Gap

Cynthia Matossian, MD, FACS had an article titled "Quick and Easy Bottom-Line Boosters" published in the November, 2013 issue of Ophthalmology Management. She discusses ways to bridge the reinbursement gap with revenue generating ideas such as hot and cold masks, omega-3 supplements, artificial tears, IPL Therapy, etc.

Click here to read the full article .

Source: Matossian, Cynthia, MD, FACs. Quick and Easy Bottom-Line Boosters: Bridging the reimbursement gap with new revenue streams. Ophthalmology Management. November 2013. pg. 28-32. http://origin.library.constantcontact.com/download/get/file/1105493388533-159/Quick+and+easy+bottom-line+boosters+OM+Nov+2013.pdf.

Month, Year
The Flip and Slice Technique is Safe and Efficient
Cynthia Matossian, MD published the article "The Flip-and-Slice Technique is Safe and Efficient" in the October 2013 issue of Cataract & Refractive Surgery Today.

To read the full article click here.

To view a video of Cynthia Matossian, MD performing the Flip-and-Slice Technique select the icon below:

null

Source: Matossian, Cynthia, MD. The Flip-and-Slice Technique is Safe and Efficient. Cataract and Refractive Surgery Today. October 2013. http://bmctoday.net/crstoday/2013/10/article.asp?f=the-flip-and-slice-technique-is-safe-and-efficient.

Month, Year
Top Doctor of 2013

This year Castle Connolly Cynthia Matossian, MDnames Cynthia Matossian, MD one of New Jersey's Top Doctors. Castle Connolly, a national consumer research firm for three decades, selected Dr. Matossian as a Top Doctor based on an intensive process of peer nomination, research, and review by the physician-led team. Dr. Matossian's specialization in cataract with implant surgery and the positive feedback received from her patients were considered in the review process.

Month, Year
MEA is Active in a Variety of Clinical Studies
  • Phase II Lifitegrast Ophthalmic Solution vs Placebo (SONATA/SARcode). This study is closed.
  • Tear Osmolarity on Pre-Surgical Calculations in Cataract Surgery. We are actively enrolling patients into this study.
  • Rapid Pathogen Screening Adeno Virus. We are looking for 'red eyes' to enroll in this study.
  • The influence of the PRN Dry Eye Omega 3 nutritional regimen in osmolarity. This study is closed.
  • Restasis Induction Study: Restasis alone, with Loteprednol Gel, or with Bromday or Prolensa. We are almost done with our patient enrollment phase.
  • Blue Light Filter Study from Alcon. We are halfway through this study.
Month, Year
Americn Academy of Ophthalmology (AAO) Annual Meeting

Cynthia Matossian, MD, FACS attended the AAO Annual Meeting in New Orleans this past November. Dr. Matossian was invited to be a speaker and panelist during meetings. A few of the highlights were:
  • Speaker at "New Age of Laser Cataract Surgery with Premium IOLs"
  • MARCO Power Forum Panel Member
  • Alphaeon Get Involved Presentation
Month, Year
Comparison of Toric IOLs

At the Ocular Surgery News meeting in New York, 2013, Cynthia Matossian, MD, discussed differences between toric IOLs available in the US market.

To view the video, click here or select the icon below:



Source: Matossian, Cynthia, MD, FACs. Surgeon Compares Toric IOLs. Healio Ophthalmology: Ocular Surgery News. September 2013. http://video.healio.com/video/Matossian;search%3Acynthia%20matossian.

Month, Year
Nationally Eye Disorders Cost $139 Billion Per Year

Direct and indirect costs associated with eye disorders and vision loss total $139 billion per year, according to a research commissioned by Prevent Blindness America (PBA). The cost of vision problems outside direct healthcare expenses, including lost productivity and long-term care costs approximately $72 billion.

The costs to government and taxpayers, including direct medical costs and long-term care is approximately $47.4 billion. The authors note that the government pays more for direct medical costs than private insurance, largely due to the Medicare-aged population 65 and older. Among those aged 65 and older, government accounts for nearly half of the total burden due to an increase in medical and long-term care expenditures. The cost to private health care companies reflects $20.8 billion.

The full article can be read here.

Source: Rajecki, Ron. July 15, 2013. Eye Disorders cost $139 billion per year: Communication, Advocacy by Ophthalmologists among Solutions. Ophthalmic Times. pgs 6-7.

Month, Year
Functional Improvement After One-and Two Cataract Surgeries

A study was done by researchers to determine the impact that cataract and cataract surgery have on clinical measurements of vision, reading speed, objective mobility performance, and subjective visual functioning.

The study included 29 participants who had cataract surgery on both eyes, 90 participants who had unilateral surgery, and 1620 participants who had not had surgery. After adjusting for baseline value, demographics, depression, and mental status, the unilateral and the bilateral surgery group's visual acuity, change in reading speed, and daily activities improved compared with no surgery.

Unilateral cataract surgery improves visual functioning, but the largest gains are found in patients who undergo second-eye cataract surgery. This finding supports second-eye cataract surgery for patients with visual or functional symptoms even after successful first-eye surgery.

To view the article, click here.

Source: Lee, Bryan S. MD, JD; Beatriz E. Munoz, MSc; Sheila K. West, PhD; Emily W. Gower, PhD. 2013. Functional Improvement after One- and Two-Eye Cataract Surgery in the Salisbury Eye Evaluation. American Academy of Ophthalmology. 120,5. Pgs 949-955.

Month, Year
About Us

Matossian Eye Associates was founded in 1987. Our professional objective is to provide every patient with excellent eye care in a personalized and caring manner.

Our practice offers a complete range of preventive and corrective eye care and surgery, using the most advanced technology available for detection and treatment of eye disease.